Sensex

up-green-arrow

Nifty

up-green-arrow

USDINR

down-red-arrow

GBPINR

down-red-arrow

EURINR

down-red-arrow

Hot Pursuit
Close

Scrips, which has significant changes during the market hours.

 
India Ratings affirmed Rs 500 crore Bank Loan and assigned IND AA+/Stable to Rs 14,000 NCDs for Jubilant Pharmova
21-Oct-26 16:46Hrs IST

Jubilant Pharmova Ltd announced credit rating actions from multiple agencies, including an unspecified agency assigning a credit rating to a not specified instrument with details not provided, and India Ratings and Research Pvt Ltd affirming the Rs 500 crore Bank Loan at IND AA with a Stable outlook, affirming the Long-Term Debt at IND A+ with a Stable outlook, and assigning a rating of IND AA+/Stable to proposed Non-Convertible Debentures of Rs 1,400.00; CRISIL upgraded the Commercial Paper from Rs 250 Crore from CRISIL A1 to CRISIL A1+; India Ratings assigned a rating of IND AA+/Stable to proposed Non-Convertible Debentures of 14,000, affirmed a Long Term Bank Loan of 500 crore at IND AAA with a Stable Outlook, and disseminated a rating communication received October 21, 2026, alongside a rating letter dated October 21, 2026, and a credible rating based on limited information; India Ratings & Research (A Fitch Group Company) issued a NCD rating letter dated October 21, 2026, while India Ratings and Research (Ind-Ra) assigned a rating of IND AA+/Stable to proposed non-convertible debentures (NCDs) of 14,000, all based on information from offering documents and reports, with additional rating data pending full text availability and no rating data found for Fitch Group or certain India Ratings & Research entities.

Attention Investor :

"Prevent unauthorised transactions in your account ; Update your mobile numbers/email IDs with Us. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day” - Issued in the interest of Investors"

"KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary."

"No need to issue cheques by investors while subscribing to Equity IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."

"Contents which are exclusively for Non-Broking Products/Services, "Mutual Fund, Mutual Fund-SIP, Research reports, Insurance, etc. where the Member is just a distributor. These are not Exchange traded product and the Member is just acting as distributor. It should also state that all disputes with respect to the distribution activity, would not have access to Exchange investor redressal forum or Arbitration mechanism."

A Muthoot M George Enterprise